STING1 and viral infectious disease: ORF3a, ORF9b, N, and 3CLPro (protease domain of Nsp5) of SARS-CoV-2 were shown to inhibit STING 79,80 and pharmacological activation of cGAS-STING reduces virus infection 81,82.